NCT07741045 — Parkinson's Disease (PD) trial site landscape

Public-registry site landscape for NCT07741045, a Parkinson's Disease (PD) study sponsored by Hangzhou PhecdaMed Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07741045 (registry record)
Sponsor	Hangzhou PhecdaMed Co., Ltd.
Condition(s)	Parkinson's Disease (PD); Parkinson Disease 6, Early-Onset
Phase	PHASE3
Listed sites	21
Site countries	China

Recruiting-density context

At Beijing Hospital — one of the facilities listed on this trial — 8 other studies are actively recruiting Parkinson's Disease (PD) patients at the same facility (public registry, as of August 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07741045 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →